Rigel Pharmaceuticals, Inc. (RIGL)
46.18
-0.30
(-0.66%)
USD |
NASDAQ |
Aug 31, 16:00
46.18
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Cash from Operations (TTM) : 79.39M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 79.39M |
| March 31, 2026 | 79.27M |
| December 31, 2025 | 75.66M |
| September 30, 2025 | 68.18M |
| June 30, 2025 | 65.83M |
| March 31, 2025 | 35.59M |
| December 31, 2024 | 31.47M |
| September 30, 2024 | 10.73M |
| June 30, 2024 | -12.31M |
| March 31, 2024 | -6.682M |
| December 31, 2023 | -5.743M |
| September 30, 2023 | -21.41M |
| June 30, 2023 | -33.35M |
| March 31, 2023 | -52.20M |
| December 31, 2022 | -73.76M |
| September 30, 2022 | -70.94M |
| June 30, 2022 | -67.93M |
| March 31, 2022 | 0.196M |
| December 31, 2021 | 5.878M |
| September 30, 2021 | 9.392M |
| June 30, 2021 | 0.207M |
| March 31, 2021 | -69.05M |
| December 31, 2020 | -52.18M |
| September 30, 2020 | -46.26M |
| June 30, 2020 | -41.42M |
| Date | Value |
|---|---|
| March 31, 2020 | -44.03M |
| December 31, 2019 | -41.51M |
| September 30, 2019 | -20.22M |
| June 30, 2019 | -25.66M |
| March 31, 2019 | -36.00M |
| December 31, 2018 | -58.83M |
| September 30, 2018 | -90.18M |
| June 30, 2018 | -87.71M |
| March 31, 2018 | -80.19M |
| December 31, 2017 | -77.56M |
| September 30, 2017 | -70.31M |
| June 30, 2017 | -75.27M |
| March 31, 2017 | -74.23M |
| December 31, 2016 | -75.89M |
| September 30, 2016 | -77.22M |
| June 30, 2016 | -64.11M |
| March 31, 2016 | -63.82M |
| December 31, 2015 | -23.41M |
| September 30, 2015 | -24.67M |
| June 30, 2015 | -33.54M |
| March 31, 2015 | -35.34M |
| December 31, 2014 | -69.75M |
| September 30, 2014 | -73.59M |
| June 30, 2014 | -76.00M |
| March 31, 2014 | -77.38M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Cytokinetics, Inc. | -555.45M |
| Perspective Therapeutics, Inc. | -93.07M |
| Capricor Therapeutics, Inc. | -104.00M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |